Murray B Gordon MD
Diabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology, Thyroid
Physician
Join to View Full Profile
420 E North AveSuite 205Pittsburgh, PA 15212
Phone+1 412-359-3426
Fax+1 412-359-6974
Dr. Gordon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1982
UPMC Medical EducationResidency, Internal Medicine, 1977 - 1980
Albany Medical CollegeClass of 1977
Certifications & Licensure
PA State Medical License 1978 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. Start of enrollment: 2011 Aug 16
- An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
- Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease Start of enrollment: 2013 Mar 28
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsLong-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER.Beverly M K Biller, Charlotte Höybye, Jean-Marc Ferran, Nicky Kelepouris, Navid Nedjatian
Journal of the Endocrine Society. 2023-05-05 - 13 citationsACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly.Monica R Gadelha, Murray B Gordon, Mirjana Doknic, Emese Mezősi, Miklós Tóth
The Journal of Clinical Endocrinology and Metabolism. 2023-04-13 - 6 citationsReduced CV risk with long-term GH replacement in AGHD: data from two large observational studies.Charlotte Höybye, Beverly M K Biller, Jean-Marc Ferran, Murray B Gordon, Nicky Kelepouris
Endocrine Connections. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
